Saturday, January 31, 2026

Feline Feeding Fiasco: Woman Fined for Trespassing

Fined KRW 500,000 after being convicted of housebreaking A...

How Britain’s Opium War Changed China Forever: Untold Story of the Treaty of Nanjing

The Treaty of Nanjing, signed in 1842, ceded Hong Kong, opened Chinese ports, and marked Western imperialism.

K-Pop Royalty Reunites: 2NE1’s Epic Comeback Concert in Seoul!

Celebrating their 15th anniversary, 2NE1 reunited after a decade, thrilling 12,000 fans with electrifying performances and celebrity guests.

Health

How a 2-Cent Sugar Tax Could Save $4.5 Billion in Healthcare Costs: California’s Bold Move

A sugar-sweetened beverage tax in California could cut obesity cases and save $4.5 billion in healthcare costs over ten years.

Unlocking Global Potential: ezCaretech’s AI-Driven Healthcare Solutions for Saudi Arabia

ezCaretech is expanding into the Middle East, focusing on Saudi Arabia, with innovative healthcare technology and global partnerships.

Celltrion’s Zymfentra: How This Breakthrough Drug is Driving Record Sales

Celltrion expects record sales driven by Zymfentra's success, expanding into new biosimilars and CDMO business for future growth.

Samsung Bioepis Expands SB15 Eylea Rival: Licensing Pact Targets Global Markets as Original Drug Hits $10.5B Sales

Samsung Bioepis has secured a licensing deal for its ophthalmic treatment SB15, expanding access in international markets outside the US and Canada.

Chinese Biotech’s Rise: What’s the Standard of Global Tech Trade?

Analysts at the JPMHC noted a shift in biotech, with firms resisting sales and China emerging as a tech transfer leader.
Latest

The Hidden Code: How RNA Editing Could Hold the Key to Parkinson’s

Korean researchers discovered that RNA editing plays a crucial role in regulating neuroinflammation in Parkinson's disease.

Misdiagnosed for Years: Ankylosing Spondylitis Cases Rise 1.5 Times Over a Decade

Ankylosing spondylitis is a chronic arthritis affecting young men, causing severe spinal pain and stiffness, requiring early diagnosis.

Tumors Shrinking, Hopes Rising: Voronoi’s VRN11 Shows Over 40% Tumor Reduction in Early Lung Cancer Trial

Voronoi's VRN11 shows promising anti-cancer efficacy in early trials, reducing tumors in resistant lung cancer patients without major side effects.

Your Gums Hurt but No Cavities? It Might Be Something Worse

Over 75% of adults suffer from periodontal disease, which can lead to tooth loss. Early detection and proper care are crucial for prevention.

Herpes and the Brain: Could a Common STI Be Fueling the Dementia Crisis?

A study reveals men with genital herpes (HSV-2) face over double the dementia risk, highlighting the need for awareness and research.

Novo Nordisk Pushes for First Oral Obesity Drug Approval

Novo Nordisk seeks FDA approval for oral Wegovy, potentially the first oral obesity treatment, amid competition with Eli Lilly.

The Cells That Start It All: KAIST Breaks Ground in Brain Cancer Research

Researchers at KAIST have identified precancerous cells in glioblastoma, revealing their role in tumor evolution and treatment resistance.

Teen Guys with ‘Man Boobs’ Are Turning to Surgery—Here’s Why

A 19-year-old struggles with gynecomastia, seeking surgery. The condition causes social distress and requires careful evaluation.

FDA Ruling Paves Way for Pharmacy Substitution of Yuflyma for Humira

Celltrion's Yuflyma receives FDA approval for interchangeability with Humira, boosting market confidence and distribution in the U.S.

New Drug Candidate Shows Promise Against Solid Tumors by Eliminating M2 Macrophages

Researchers have developed a peptide drug that targets M2 macrophages, enhancing solid tumor immunotherapy effectiveness.

GIST Team Develops Real-Time Blood Flow Sensor with Dual Hydration Modeling

A South Korean team developed a technology for real-time genetic analysis of blood components, enhancing blood test accuracy significantly.

Eli Lilly’s Oral GLP-1 Shows 7.9% Weight Loss in Type 2 Diabetes Trial

Eli Lilly's orforglipron shows promise in Phase 3 trials for diabetes and obesity, offering an oral alternative to injectables.

Sandoz: Millions of Patients Denied Access to Affordable Enbrel Alternative

Sandoz has filed an antitrust lawsuit against Amgen to challenge patent practices blocking its biosimilar, Erelzi, from market entry.

Thread Lifts in Your 20s? Why Gen Z Is Getting a Head Start on Aging

Interest in slow aging rises among young adults, leading to increased thread-lifting procedures for skin rejuvenation and elasticity.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.